The effect of peroxynitrite decomposition catalyst MnTBAP on aldehyde dehydrogenase-2 nitration by organic nitrates: role in nitrate tolerance.

[1]  C. Stefanadis,et al.  Stable Angina Pectoris: Current Medical Treatment , 2013 .

[2]  A. Curnis,et al.  When should we use nitrates in congestive heart failure? , 2013, Cardiovascular therapeutics.

[3]  G. Oberdorfer,et al.  Vascular Bioactivation of Nitroglycerin by Aldehyde Dehydrogenase-2 , 2012, The Journal of Biological Chemistry.

[4]  Julio C. B. Ferreira,et al.  Nitroglycerin use in myocardial infarction patients. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[5]  S. Jo,et al.  Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications. , 2011, Journal of proteomics.

[6]  T. Münzel,et al.  Contemporary Reviews in Cardiovascular Medicine Nitrate Therapy New Aspects Concerning Molecular Action and Tolerance , 2011 .

[7]  T. Münzel,et al.  Regulation of Human Mitochondrial Aldehyde Dehydrogenase (ALDH-2) Activity by Electrophiles in Vitro* , 2011, The Journal of Biological Chemistry.

[8]  W. Frishman,et al.  The Antiplatelet Effects of Nitrates: Is it of Clinical Significance in Patients With Cardiovascular Disease? , 2010, Cardiology in review.

[9]  T. Münzel,et al.  Organic nitrates and nitrate tolerance--state of the art and future developments. , 2010, Advances in pharmacology.

[10]  T. Münzel,et al.  Nitrate reductase activity of mitochondrial aldehyde dehydrogenase (ALDH-2) as a redox sensor for cardiovascular oxidative stress. , 2010, Methods in molecular biology.

[11]  K. Lackner,et al.  Nitrate tolerance as a model of vascular dysfunction: Roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress , 2009, Pharmacological reports : PR.

[12]  B. Mayer,et al.  The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles , 2008, British journal of pharmacology.

[13]  T. Gori,et al.  The mechanism of nitrate-induced preconditioning. , 2008, Clinical hemorheology and microcirculation.

[14]  C. Vahl,et al.  Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. , 2007, Journal of the American College of Cardiology.

[15]  D. Sheehan,et al.  Proteomic identification of tyrosine nitration targets in kidney of spontaneously hypertensive rats , 2007, Proteomics.

[16]  T. Meinertz,et al.  Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. , 2007, Journal of molecular and cellular cardiology.

[17]  T. Münzel,et al.  New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance , 2007, Clinical Research in Cardiology.

[18]  T. Münzel,et al.  Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. , 2005, Biochemical and biophysical research communications.

[19]  B. Lopez,et al.  Nitrate tolerance aggravates postischemic myocardial apoptosis and impairs cardiac functional recovery after ischemia , 2005, Apoptosis.

[20]  G. Kojda,et al.  Organic nitrates in cardiovascular disease. , 2005, Cellular and molecular biology.

[21]  J. Loscalzo,et al.  ATVB In Focus Redox Mechanisms in Blood Vessels , 2005 .

[22]  R. Caldwell,et al.  Roles of Superoxide, Peroxynitrite, and Protein Kinase C in the Development of Tolerance to Nitroglycerin , 2004, Journal of Pharmacology and Experimental Therapeutics.

[23]  J. Abrams.  How to Use Nitrates , 2002, Cardiovascular Drugs and Therapy.

[24]  J. Bauer,et al.  Mechanisms of nitrate tolerance , 1994, Cardiovascular Drugs and Therapy.

[25]  F. Hofmann,et al.  Physiology and Pathophysiology of Vascular Signaling Controlled by Cyclic Guanosine 3′,5′-Cyclic Monophosphate–Dependent Protein Kinase , 2003 .

[26]  J. Floras,et al.  Effects of nitroglycerin treatment on baroreflex sensitivity and short-term heart rate variability in humans. , 2002, Journal of the American College of Cardiology.

[27]  T. Gori,et al.  Nitrate tolerance: a unifying hypothesis. , 2002, Circulation.

[28]  U. Walter,et al.  Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits. , 2002, Journal of the American College of Cardiology.

[29]  J. Stamler,et al.  Identification of the enzymatic mechanism of nitroglycerin bioactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Harrison,et al.  Evidence for a causal role of the renin-angiotensin system in nitrate tolerance. , 1999, Circulation.

[31]  T. Münzel,et al.  Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo. , 1996, Circulation.

[32]  D. Harrison,et al.  Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease. , 1996, Journal of the American College of Cardiology.

[33]  J. Vane,et al.  Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Vane,et al.  Studies on the importance of the proposed release of nitric oxide from platelets. , 1991, Thrombosis research.

[35]  J. Parker,et al.  Counter‐Regulatory Responses to Continuous and Intermittent Therapy With Nitroglycerin , 1991, Circulation.

[36]  J. Abrams.  Clinical aspects of nitrate tolerance. , 1991, European heart journal.

[37]  J. Vane,et al.  Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols. , 1991, The Journal of pharmacology and experimental therapeutics.

[38]  J. Bauer,et al.  Concurrent Hydralazine Administration Prevents Nitroglycerin‐Induced Hemodynamic Tolerance in Experimental Heart Failure , 1991, Circulation.

[39]  J. Vane,et al.  Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation. , 1991, European journal of pharmacology.

[40]  S. Moncada,et al.  An improved method for washing of human platelets with prostacyclin. , 1983, Thrombosis research.

[41]  J. Parker,et al.  Oral Isosorbide Dinitrate in the Treatment of Angina Pectoris: Dose‐Response Relationship and Duration of Action During Acute Therapy , 1980, Circulation.

[42]  G. Brooker,et al.  Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution. , 1975, Journal of cyclic nucleotide research.

[43]  M. Steiner.  LIPID AND AMINO ACID SYNTHESIS IN AGGREGATING PLATELETS * , 1972, Annals of the New York Academy of Sciences.

[44]  G. Born,et al.  The aggregation of blood platelets , 1963, The Journal of physiology.

[45]  G. Born,et al.  Effect of Adenosine Diphosphate on the Concentration of Platelets in Circulating Blood , 1963, Nature.